“A Framework for Decision Making of Migraine Treatment With Anti- CGRP Monoclonal Antibodies: A Guide for Real-World Practice and Public Policies”. 2020. Headache Medicine 11 (3): 72-76. https://doi.org/10.48208/HeadacheMed.2020.20.